← Back to Search

Modified Breath Test for Sedentary Lifestyle (BTLP Trial)

N/A
Recruiting
Led By Daniel R Moore, PhD
Research Sponsored by University of Toronto
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Healthy young individuals aged 18-35 years
If non-OC user, must have regular menstrual cycles (length: 25-35 days) for at least 3 months prior to study and at least 6 months off of OCs
Must not have
Regular use of NSAID (except low-dose aspirin), anticoagulants
Use of illicit drugs (growth hormones, testosterone)
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 6 days (during at-home phase)
Awards & highlights
No Placebo-Only Group

Summary

This trial is trying to improve a breath test method that can help identify when someone might be at risk of losing body or muscle mass. The researchers want to see if using a lower amount of dietary amino

Who is the study for?
This trial is for people who live a sedentary lifestyle or are interested in how their body processes proteins during different activity levels, like resting, less movement, or resistance exercise. Participants should not have allergies that affect the study and must be able to perform physical tasks as required.
What is being tested?
The study is testing a modified breath test method to see how well it measures protein processing by the body under various conditions: normal daily activities, reduced steps (less walking and moving), and after resistance exercises like weight lifting.
What are the potential side effects?
Since this trial involves habitual activities and changes in exercise routines rather than medication or invasive procedures, side effects are minimal but may include muscle soreness from resistance training.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am between 18 and 35 years old and healthy.
Select...
I have regular menstrual cycles and haven't used birth control pills for 6 months.

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:
Select...
I regularly use NSAIDs or blood thinners, but not low-dose aspirin.
Select...
I do not use illicit drugs like growth hormones or testosterone.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~6 days (during at-home phase)
This trial's timeline: 3 weeks for screening, Varies for treatment, and 6 days (during at-home phase) for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Exogenous Leucine Oxidation (umol/kg)
Net Leucine Retention (umol/kg)
Other study objectives
Feeling and Felt Arousal (Likert Scale)

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups
Active Control
Group I: At-Home PhaseActive Control2 Interventions
Habitual Activity + Step-Reduction Metabolic Trials
Group II: In-Person PhaseActive Control2 Interventions
Habitual Activity + Resistance Exercise Metabolic Trials

Find a Location

Who is running the clinical trial?

University of TorontoLead Sponsor
719 Previous Clinical Trials
1,042,540 Total Patients Enrolled
Ines Kortebi, MScStudy DirectorUniversity of Toronto
Hugo JW Fung, PhD (c)Study ChairUniversity of Toronto
2 Previous Clinical Trials
42 Total Patients Enrolled
~1 spots leftby Dec 2024
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top